Proscia's Leap Towards Precision Medicine!

Send us a textIn this episode, we dive into the heart of digital pathology's evolution with David West, CEO of Proscia, a company at the forefront of transforming pathology into a data-driven discipline. Proscia has recently made headlines with its FDA 510(k) clearance for Concentriq AP-Dx, marking a significant milestone in harnessing AI for enhanced diagnostic accuracy. Join us as we explore how Proscia's Concentriq® platform and its suite of AI applications are pioneering the shift towards precision medicine, promising to improve patient outcomes, accelerate research, and overcome the challenges of modern pathology. From the inception of Proscia at Johns Hopkins University to becoming a global leader with its innovative solutions, learn how they're not just adapting to the future—they're creating it. Discover the vision, technology, and passion behind Proscia's mission to perfect cancer diagnosis and what this means for the future of healthcare.